InvestSMART

Amplia Therapeutics Limited (ASX: ATX) - Announcements

- Current share price for ATX : $0.079

ASX company news and announcements for Amplia Therapeutics Limited (ATX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Amplia Therapeutics Limited (ATX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Amplia Therapeutics Limited (ATX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Amplia Therapeutics Limited (ATX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$41 Change of Director's Interest Notice - Dr Robert Peach 20 Dec 2024 6:08PM $0.083 $0.079 fallen by 4.82%
$41 Change of Director's Interest Notice - Ms Jane Bell 20 Dec 2024 6:08PM $0.083 $0.079 fallen by 4.82%
$41 Top 20 Holders and Range of Units for Attaching Options 20 Dec 2024 3:07PM $0.084 $0.079 fallen by 5.95%
$41 Application for quotation of securities - ATX 20 Dec 2024 3:06PM $0.084 $0.079 fallen by 5.95%
$41 Application for quotation of securities - ATX 20 Dec 2024 3:05PM $0.084 $0.079 fallen by 5.95%
$41 Notification regarding unquoted securities - ATX 20 Dec 2024 12:23PM $0.085 $0.079 fallen by 7.06%
$41 Results of Meeting - EGM 19 Dec 2024 19 Dec 2024 2:43PM $0.083 $0.079 fallen by 4.82%
$41 Positive Data Strong Recruitment in Pancreatic Cancer Trial 11 Dec 2024 8:42AM $0.086 $0.079 fallen by 8.14%
$41 Application for quotation of securities - ATX 28 Nov 2024 10:30AM $0.089 $0.079 fallen by 11.24%
$41 Change in substantial holding 27 Nov 2024 4:22PM $0.087 $0.079 fallen by 9.20%
$41 App 4D and Financial Report Half Year ended 30 Sep 2024 27 Nov 2024 2:51PM $0.086 $0.079 fallen by 8.14%
$41 Successful Completion of Retail Entitlement Offer 27 Nov 2024 8:45AM $0.092 $0.079 fallen by 14.13%
$41 Security Class Suspension from Quotation 25 Nov 2024 9:13AM $0.088 $0.079 fallen by 10.23%
$41 Notice of Extraordinary General Meeting/Proxy Form 18 Nov 2024 4:30PM $0.094 $0.079 fallen by 15.96%
$41 Amplia Enters into Preclinical Collaboration 14 Nov 2024 9:16AM $0.100 $0.079 fallen by 21%
$41 Change in substantial holding 8 Nov 2024 5:03PM $0.093 $0.079 fallen by 15.05%
$41 Section 708A(5)(e) Notice - Allotment of 67,723,015 Shares 7 Nov 2024 2:28PM $0.094 $0.079 fallen by 15.96%
$41 Substantial Holder Notice - Blueflag Holding Pty Ltd 6 Nov 2024 4:18PM $0.096 $0.079 fallen by 17.71%
$41 Application for quotation of securities - ATX 6 Nov 2024 11:33AM $0.103 $0.079 fallen by 22.93%
$41 Proposed issue of securities - ATX 5 Nov 2024 9:33AM $0.105 $0.079 fallen by 24.76%
$41 Update - Proposed issue of securities - ATX 1 Nov 2024 10:39AM $0.135 $0.079 fallen by 41.48%
$41 Replacement Prospectus 1 Nov 2024 10:38AM $0.135 $0.079 fallen by 41.48%
$41 Amplia Successfully Completes Institutional Offer 1 Nov 2024 10:35AM $0.135 $0.079 fallen by 41.48%
$41 Proposed issue of securities - ATX 31 Oct 2024 8:23AM $0.135 $0.079 fallen by 41.48%
$41 Proposed issue of securities - ATX 30 Oct 2024 11:46AM $0.135 $0.079 fallen by 41.48%

126 - 150 of 547 results

Page 6 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.